With NXR merger agreement at these price levels, some arbitrage opportunities may exist on ARQ.Downside severely limited by NXS merger offer. Upside relative to AWE aggression and AWE ego.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game